Search
  • Quick Search in Journals
  • Quick Search anywhere
  • Quick search in Citations
Advanced Search
Menu
  • Information
    • Previous
    Next
    Original Research

    Proton MR Spectroscopy with Choline Peak as Malignancy Marker Improves Positive Predictive Value for Breast Cancer Diagnosis: Preliminary Study

    Published Online:Jun 1 2006https://doi.org/10.1148/radiol.2393051046

    Abstract

    Purpose: To prospectively evaluate the diagnostic performance of magnetic resonance (MR) spectroscopy in patients with suspicious lesions or biopsy-proved cancers at MR imaging by using histologic findings as the reference standard.

    Materials and Methods: After institutional review board approval and informed consent were obtained for this HIPAA-compliant study, breast MR spectroscopy was performed in patients with suspicious or biopsy-proved malignant lesions measuring 1 cm or larger at MR imaging. Single-voxel MR spectroscopy data were collected from a single rectangular volume of interest that encompassed the lesion. MR spectroscopy findings were defined as positive if the signal-to-noise ratio of the choline resonance peak was greater than or equal to 2 and as negative in all other cases. MR spectroscopy findings were then compared with histologic findings.

    Results: A total of 56 patients (age range, 20–77 years) with 57 lesions were imaged. The median lesion size at MR imaging was 2.3 cm (range, 1–15 cm). Histologically, 31 (54%) of 57 lesions were malignant, and 26 (46%) were benign. A choline peak was present in 34 of 57 lesions (including all cancers) and in three of 26 benign lesions, giving MR spectroscopy a sensitivity of 100% and a specificity of 88%. In 40 lesions of unknown histologic type, the use of MR spectroscopy as an adjunct to MR imaging would have significantly (P < .01) increased the positive predictive value of biopsy from 35% to 82%. If biopsy had been performed only on those lesions with a choline peak at MR spectroscopy, biopsy may have been spared in 23 (58%) of 40 lesions, and none of the cancers would have been missed.

    Conclusion: Proton MR spectroscopy was successfully incorporated into breast MR imaging studies for lesions measuring 1 cm or larger. This technique may be useful in reducing the number of lesions detected at MR imaging that require biopsy.

    © RSNA, 2006

    References

    • 1 Liberman L. Breast cancer screening with MRI: what are the data for patients at high risk? N Engl J Med 2004; 351: 497–500. Crossref, Medline, Google Scholar
    • 2 Robson ME, Offit K. Breast MRI for women with hereditary cancer risk. JAMA 2004;292:1368–1370. Crossref, Medline, Google Scholar
    • 3 Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181:619–626. Crossref, Medline, Google Scholar
    • 4 Boetes C, Stoutjesdijk M. MR imaging in screening women at increased risk for breast cancer. Magn Reson Imaging Clin N Am 2001;9:357–372. Medline, Google Scholar
    • 5 Morris EA. Review of breast MRI: indications and limitations. Semin Roentgenol 2001;36:226–237. Crossref, Medline, Google Scholar
    • 6 Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13–30. Link, Google Scholar
    • 7 Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303–324. Crossref, Medline, Google Scholar
    • 8 Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661–666. Link, Google Scholar
    • 9 Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80–84. Medline, Google Scholar
    • 10 Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002;225:190–197. Link, Google Scholar
    • 11 Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy—initial results. Radiology 2001;220:40–46. Link, Google Scholar
    • 12 Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999;10:159–164. Crossref, Medline, Google Scholar
    • 13 Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68:45–54. Crossref, Medline, Google Scholar
    • 14 Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209:269–275. Link, Google Scholar
    • 15 Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998;8:1191–1197. Crossref, Medline, Google Scholar
    • 16 Tse GM, Cheung HS, Pang LM, et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 2003;181:1267–1272. Crossref, Medline, Google Scholar
    • 17 Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 2003;50:1134–1143. Crossref, Medline, Google Scholar
    • 18 Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004;232:585–591. Link, Google Scholar
    • 19 Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004;19:68–75. Crossref, Medline, Google Scholar
    • 20 Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001;84:1016–1022. Crossref, Medline, Google Scholar
    • 21 Meisamy S, Bolan PJ, Baker EH, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy—a pilot study at 4 T. Radiology 2004;233:424–431. Link, Google Scholar
    • 22 Liberman L, Morris EA, Dershaw DD, Thornton CM, Van Zee KJ, Tan LK. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol 2003;181:1283–1293. Crossref, Medline, Google Scholar
    • 23 Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol 2002;178:1211–1220. Crossref, Medline, Google Scholar
    • 24 American College of Radiology. ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. Reston, Va: American College of Radiology, 2003. Google Scholar
    • 25 Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 2000;56:345–351. Crossref, Medline, Google Scholar

    Article History

    Published in print: June 2006